Agios Pharma (AGIO) Misses Q2 EPS by 12c

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.93), $0.12 worse than the analyst estimate of ($1.81). Revenue for the quarter came in at $12.45 million versus the consensus estimate of $9.54 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• U.S. presses Meta to agree to A.I. reviews as security concerns rise - NYT
• Alphabet added to Dow Jones Industrial Average, Verizon dropped